Differential profile of PIP4K2A expression in hematological malignancies (2015)
- Authors:
- Autor USP: TRAINA, FABÍOLA - FMRP
- Unidade: FMRP
- DOI: 10.1016/j.bcmd.2015.06.014
- Subjects: LEUCEMIA; HEMATOLOGIA; FOSFOLIPÍDEOS
- Language: Inglês
- Imprenta:
- Publisher place: Maryland Heights
- Date published: 2015
- Source:
- Título: Blood Cells, Molecules and Diseases
- ISSN: 1079-9796
- Volume/Número/Paginação/Ano: v. 55, p. 228-235, 2015
- Este periódico é de assinatura
- Este artigo NÃO é de acesso aberto
- Cor do Acesso Aberto: closed
-
ABNT
LIMA, Keli et al. Differential profile of PIP4K2A expression in hematological malignancies. Blood Cells, Molecules and Diseases, v. 55, p. 228-235, 2015Tradução . . Disponível em: https://doi.org/10.1016/j.bcmd.2015.06.014. Acesso em: 27 dez. 2025. -
APA
Lima, K., Ribeiro, D. M., Campos, P. de M., Costa, F. F., Traina, F., Saad, S. T. O., et al. (2015). Differential profile of PIP4K2A expression in hematological malignancies. Blood Cells, Molecules and Diseases, 55, 228-235. doi:10.1016/j.bcmd.2015.06.014 -
NLM
Lima K, Ribeiro DM, Campos P de M, Costa FF, Traina F, Saad STO, Sonati M de F, Machado Neto JA. Differential profile of PIP4K2A expression in hematological malignancies [Internet]. Blood Cells, Molecules and Diseases. 2015 ; 55 228-235.[citado 2025 dez. 27 ] Available from: https://doi.org/10.1016/j.bcmd.2015.06.014 -
Vancouver
Lima K, Ribeiro DM, Campos P de M, Costa FF, Traina F, Saad STO, Sonati M de F, Machado Neto JA. Differential profile of PIP4K2A expression in hematological malignancies [Internet]. Blood Cells, Molecules and Diseases. 2015 ; 55 228-235.[citado 2025 dez. 27 ] Available from: https://doi.org/10.1016/j.bcmd.2015.06.014 - FMNL1 is downregulated in myelodysplastic syndromes and is involved in megakaryocytic differentiation
- Increased inflammatory markers and their correlations to clinical complications in hemoglobin SC disease
- YAP1 expression in myelodysplastic syndromes and acute leukemias. [Carta]
- ANKHD1, a novel component of the Hippo signaling pathway, promotes YAP1 activation and cell cycle progression in prostate cancer cells
- Abnormal Hedgehog pathway in myelodysplastic syndrome and its impact on patients' outcome. [Carta]
- Key endothelial cell angiogenic mechanisms are stimulated by the circulating milieu in sickle cell disease and attenuated by hydroxyurea
- IRS2 silencing increases apoptosis and potentiates the effects of ruxolitinib in JAK2V617F-positive myeloproliferative neoplasms
- Padronização da investigação laboratorial de anticorpos dirigidos contra fármacos em doadores de sangue e pacientes com anemia hemolítica imune
- Hedgehog pathway is deregulated in myelodysplastic syndrome progenitor bone marrow cells
- IRS2 associates with JAK2 and may be involved in cell proliferation pathways in chronic myeloproliferative neoplasms
Informações sobre o DOI: 10.1016/j.bcmd.2015.06.014 (Fonte: oaDOI API)
How to cite
A citação é gerada automaticamente e pode não estar totalmente de acordo com as normas
